Last updated: May 21, 2023
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colon Cancer; Rectal Cancer
Treatment
ICG-marking endoscopically
Clinical Study ID
NCT04959604
CCLNM
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoidcolon.
Exclusion
Exclusion Criteria:
- not wanting to participate
- other carcinoma then adenocarcinoma
- endoscopic marking not possible
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: ICG-marking endoscopically
Phase:
Study Start date:
May 31, 2021
Estimated Completion Date:
December 30, 2026
Study Description
Connect with a study center
University of Hamburg Medical Institutions
Hamburg,
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.